e-learning
resources
Glasgow 2004
Monday 06.09.2004
Thrombo-embolic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fixed or weight-adjusted dosis of enoxaparin as prophylaxis for venous thromboembolism in acutelly ill medical patients
D. Jiménez, G. Díaz, E. Pérez-Rodríguez, S. García-Rull, R. Vidal, A. Sueiro (Madrid, Spain)
Source:
Annual Congress 2004 - Thrombo-embolic diseases
Session:
Thrombo-embolic diseases
Session type:
Thematic Poster Session
Number:
1786
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Jiménez, G. Díaz, E. Pérez-Rodríguez, S. García-Rull, R. Vidal, A. Sueiro (Madrid, Spain). Fixed or weight-adjusted dosis of enoxaparin as prophylaxis for venous thromboembolism in acutelly ill medical patients. Eur Respir J 2004; 24: Suppl. 48, 1786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Incidence of venous thromboembolism 8-weeks post discharge in hospitalised medical patients not receiving thrombo-prophylaxis
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Efficiency of r-TPA therapy in major venous thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 83s
Year: 2007
Complications of anticoagulant therapy in patients with pulmonary thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 604s
Year: 2007
Enoxaparin versus unfractionated heparin in acute pulmonary thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 237s
Year: 2002
Treatment of VTE during pregnancy with a once-daily regimen of LMWH
Source: Annual Congress 2007 - Acute and chronic pulmonary embolism
Year: 2007
Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020
Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021
Effectiveness of thrombolytic therapy in pulmonary thromboembolism
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Direct oral anticoagulants and venous thromboembolism
Source: Eur Respir Rev 2016; 25: 295-302
Year: 2016
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Source: Eur Respir J 2016; 48: 1369-1376
Year: 2016
Comparison of two regimens of oral anticoagulation in pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 632s
Year: 2006
Rivaroxaban versus standard anticoagulation for the treatment of pulmonary embolism: a real-life study
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Venous thromboembolism (VTE) prophylaxis in acute medical admissions to a university hospital
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE)
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019
Sticker reminders improve VTE prophylaxis appropriatness in hospitalized patients
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients
Source: Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016
Year: 2017
Venous thrombo-embolism prophylaxis
Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept